I mean, the further down the track we get in terms of "de-risk" the better for us long term holders.
the more confidence we can have in the project. EMS will keep plugging away at it.
it's not as though we are unsure whether this artimist project is all pie in the sky - it actually works!
it is clinically proven.
sure, let's get the formalities over and done with - but the board has reasoned that it is in the best interest of the project/company/offers from big pharmas/commercialization to do a properly sized III trial.
clyde r u still with us??, page-21
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $2.159M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $14.08K | 741.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 242449 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 230500 | 2 |
View Market Depth
| Last trade - 13.26pm 31/10/2024 (20 minute delay) ? |
| EMS (ASX) Chart |